Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Adicet Bio, Inc. (TORC)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/03/2023 |
4
| Galimi Francesco (SVP & Chief Medical Officer) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Paid exercise price by delivering 8,093 shares
@ $1.37, valued at
$11.1k
|
|
10/03/2023 |
4
| Healey Don (Chief Technology Officer) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Paid exercise price by delivering 9,069 shares
@ $1.37, valued at
$12.4k
|
|
10/03/2023 |
4
| Harvey Brian Nicholas (CFO) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Paid exercise price by delivering 7,096 shares
@ $1.37, valued at
$9.7k
|
|
10/02/2023 |
4
| Schor Chen (President & CEO) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Sold 5,500 shares
@ $1.42, valued at
$7.8k
Bought 5,500 shares
@ $1.42, valued at
$7.8k
Sold 5,500 shares
@ $1.3601, valued at
$7.5k
Bought 5,500 shares
@ $1.3345, valued at
$7.3k
Paid exercise price by delivering 23,208 shares
@ $1.37, valued at
$31.8k
|
|
08/16/2023 |
4
| Schor Chen (President & CEO) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Disposed/sold 36,857 options to buy
@ $0 Granted 36,857 options to buy
@ $0 Disposed/sold 872,111 options to buy
@ $16.11, valued at
$14M
Granted 872,111 options to buy
@ $0 Disposed/sold 240,000 options to buy
@ $13.27, valued at
$3.2M
Granted 240,000 options to buy
@ $0 Disposed/sold 421,600 options to buy
@ $16.82, valued at
$7.1M
Granted 421,600 options to buy
@ $0 Disposed/sold 295,000 options to buy
@ $15.52, valued at
$4.6M
Granted 295,000 options to buy
@ $0 Disposed/sold 384,900 options to buy
@ $9.05, valued at
$3.5M
|
|
08/16/2023 |
4
| Galimi Francesco (SVP & Chief Medical Officer) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Disposed/sold 113,652 options to buy
@ $5.97, valued at
$678.5k
Granted 113,652 options to buy
@ $0 Disposed/sold 77,269 options to buy
@ $16.11, valued at
$1.2M
Granted 77,269 options to buy
@ $0 Disposed/sold 73,964 options to buy
@ $13.27, valued at
$981.5k
Granted 73,964 options to buy
@ $0 Disposed/sold 26,625 options to buy
@ $16.82, valued at
$447.8k
Granted 26,625 options to buy
@ $0 Disposed/sold 125,000 options to buy
@ $15.52, valued at
$1.9M
Granted 125,000 options to buy
@ $0 Disposed/sold 117,200 options to buy
@ $9.05, valued at
$1.1M
|
|
08/16/2023 |
4
| Aftab Blake (Chief Scientific Officer) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Disposed/sold 50,000 options to buy
@ $15.93, valued at
$796.5k
Granted 50,000 options to buy
@ $0 Disposed/sold 56,612 options to buy
@ $7.38, valued at
$417.8k
Granted 56,612 options to buy
@ $0 Disposed/sold 125,000 options to buy
@ $15.52, valued at
$1.9M
Granted 125,000 options to buy
@ $0 Disposed/sold 60,000 options to buy
@ $12.18, valued at
$730.8k
Granted 60,000 options to buy
@ $0 Disposed/sold 117,200 options to buy
@ $9.05, valued at
$1.1M
Granted 117,200 options to buy
@ $0 |
|
08/16/2023 |
4
| Harvey Brian Nicholas (CFO) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Disposed/sold 90,000 options to buy
@ $13.27, valued at
$1.2M
Granted 90,000 options to buy
@ $0 Disposed/sold 28,200 options to buy
@ $16.82, valued at
$474.3k
Granted 28,200 options to buy
@ $0 Disposed/sold 125,000 options to buy
@ $15.52, valued at
$1.9M
Granted 125,000 options to buy
@ $0 Disposed/sold 117,200 options to buy
@ $9.05, valued at
$1.1M
Granted 117,200 options to buy
@ $0 Granted 176,308 options to buy
@ $2.14, valued at
$377.3k
|
|
08/16/2023 |
4
| Healey Don (Chief Technology Officer) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Disposed/sold 70,000 options to buy
@ $13.27, valued at
$928.9k
Granted 70,000 options to buy
@ $0 Disposed/sold 30,400 options to buy
@ $16.82, valued at
$511.3k
Granted 30,400 options to buy
@ $0 Disposed/sold 125,000 options to buy
@ $15.52, valued at
$1.9M
Granted 125,000 options to buy
@ $0 Disposed/sold 117,200 options to buy
@ $9.05, valued at
$1.1M
Granted 117,200 options to buy
@ $0 Granted 149,944 options to buy
@ $2.14, valued at
$320.9k
|
|
08/16/2023 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Disposed/sold 30,000 options to buy
@ $16.11, valued at
$483.3k
Granted 30,000 options to buy
@ $0 Disposed/sold 18,500 options to buy
@ $15.93, valued at
$294.7k
Granted 18,500 options to buy
@ $0 Disposed/sold 18,500 options to buy
@ $11.49, valued at
$212.6k
Disposed/sold 26,400 options to buy
@ $5.195, valued at
$137.1k
Granted 26,400 options to buy
@ $0 |
|
08/16/2023 |
4
| Sanna Bastiano (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Disposed/sold 28,828 options to buy
@ $12, valued at
$345.9k
Granted 28,828 options to buy
@ $0 Disposed/sold 18,500 options to buy
@ $15.93, valued at
$294.7k
Granted 18,500 options to buy
@ $0 Disposed/sold 1,172 options to buy
@ $15.93, valued at
$18.7k
Granted 1,172 options to buy
@ $0 Disposed/sold 18,500 options to buy
@ $11.49, valued at
$212.6k
Disposed/sold 26,400 options to buy
@ $5.195, valued at
$137.1k
Granted 26,400 options to buy
@ $0 |
|
08/16/2023 |
4
| Sinclair Andrew (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Disposed/sold 28,828 options to buy
@ $15.75, valued at
$454k
Granted 28,828 options to buy
@ $0 Disposed/sold 18,500 options to buy
@ $15.93, valued at
$294.7k
Granted 18,500 options to buy
@ $0 Disposed/sold 8,172 options to buy
@ $15.93, valued at
$130.2k
Granted 8,172 options to buy
@ $0 Disposed/sold 18,500 options to buy
@ $11.49, valued at
$212.6k
Disposed/sold 26,400 options to buy
@ $5.195, valued at
$137.1k
Granted 26,400 options to buy
@ $0 |
|
08/16/2023 |
4
| Kauffman Michael (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Disposed/sold 37,000 options to buy
@ $9.39, valued at
$347.4k
Granted 37,000 options to buy
@ $0 Disposed/sold 18,500 options to buy
@ $11.49, valued at
$212.6k
Granted 18,500 options to buy
@ $0 Disposed/sold 26,400 options to buy
@ $5.195, valued at
$137.1k
Granted 26,400 options to buy
@ $0 |
|
08/16/2023 |
4
| DUBIN STEVE (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Disposed/sold 30,000 options to buy
@ $16.11, valued at
$483.3k
Granted 30,000 options to buy
@ $0 Disposed/sold 18,500 options to buy
@ $15.93, valued at
$294.7k
Granted 18,500 options to buy
@ $0 Disposed/sold 18,500 options to buy
@ $11.49, valued at
$212.6k
Disposed/sold 26,400 options to buy
@ $5.195, valued at
$137.1k
Granted 26,400 options to buy
@ $0 |
|
08/16/2023 |
4
| Jakobovits Aya (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Disposed/sold 30,000 options to buy
@ $16.11, valued at
$483.3k
Granted 30,000 options to buy
@ $0 Disposed/sold 18,500 options to buy
@ $15.93, valued at
$294.7k
Granted 18,500 options to buy
@ $0 Disposed/sold 18,500 options to buy
@ $11.49, valued at
$212.6k
Disposed/sold 26,400 options to buy
@ $5.195, valued at
$137.1k
Granted 26,400 options to buy
@ $0 |
|
08/16/2023 |
4
| Chodakewitz Jeffrey (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Disposed/sold 30,000 options to buy
@ $16.11, valued at
$483.3k
Granted 30,000 options to buy
@ $0 Disposed/sold 18,500 options to buy
@ $15.93, valued at
$294.7k
Granted 18,500 options to buy
@ $0 Disposed/sold 18,500 options to buy
@ $11.49, valued at
$212.6k
Disposed/sold 26,400 options to buy
@ $5.195, valued at
$137.1k
Granted 26,400 options to buy
@ $0 |
|
08/16/2023 |
4
| Peng Katie (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Disposed/sold 70,200 options to buy
@ $3.38, valued at
$237.3k
Granted 70,200 options to buy
@ $0 |
|
07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2023 |
4
| DUBIN STEVE (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Bought 5,000 shares
@ $2.3999, valued at
$12k
|
|
06/29/2023 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Bought 125,000 shares
@ $2.09, valued at
$261.3k
Bought 250,000 shares
@ $2.09, valued at
$522.5k
Bought 442,000 shares
@ $2.09, valued at
$923.8k
Bought 58,000 shares
@ $2.09, valued at
$121.2k
|
|
06/29/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Bought 125,000 shares
@ $2.09, valued at
$261.3k
Bought 250,000 shares
@ $2.09, valued at
$522.5k
Bought 442,000 shares
@ $2.09, valued at
$923.8k
Bought 58,000 shares
@ $2.09, valued at
$121.2k
|
|
06/02/2023 |
4
| Chodakewitz Jeffrey (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Granted 5,900 shares
@ $0 Granted 26,400 options to buy
@ $5.195, valued at
$137.1k
|
|
06/02/2023 |
4
| Sanna Bastiano (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Granted 5,900 shares
@ $0 Granted 26,400 options to buy
@ $5.195, valued at
$137.1k
|
|
06/02/2023 |
4
| Kauffman Michael (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Granted 5,900 shares
@ $0 Granted 26,400 options to buy
@ $5.195, valued at
$137.1k
|
|
06/02/2023 |
4
| Jakobovits Aya (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Granted 5,900 shares
@ $0 Granted 26,400 options to buy
@ $5.195, valued at
$137.1k
|
|
06/02/2023 |
4
| GORDON CARL L (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Granted 5,900 shares
@ $0 Granted 26,400 options to buy
@ $5.195, valued at
$137.1k
|
|
06/02/2023 |
4
| DUBIN STEVE (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Granted 5,900 shares
@ $0 Granted 26,400 options to buy
@ $5.195, valued at
$137.1k
|
|
06/02/2023 |
4
| Sinclair Andrew (Director) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Granted 5,900 shares
@ $0 Granted 26,400 options to buy
@ $5.195, valued at
$137.1k
|
|
02/14/2023 |
4
| Healey Don (Chief Technology Officer) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Sold 10,467 shares
@ $7.9752, valued at
$83.5k
|
|
01/26/2023 |
4
| Galimi Francesco (SVP & Chief Medical Officer) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Granted 26,100 shares
@ $0 Granted 117,200 options to buy
@ $9.05, valued at
$1.1M
|
|
01/26/2023 |
4
| Harvey Brian Nicholas (CFO) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Granted 26,100 shares
@ $0 Granted 117,200 options to buy
@ $9.05, valued at
$1.1M
|
|
01/26/2023 |
4
| Healey Don (Chief Technology Officer) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Granted 26,100 shares
@ $0 Granted 117,200 options to buy
@ $9.05, valued at
$1.1M
|
|
01/26/2023 |
4
| Aftab Blake (Chief Scientific Officer) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Granted 26,100 shares
@ $0 Granted 117,200 options to buy
@ $9.05, valued at
$1.1M
|
|
01/26/2023 |
4
| Schor Chen (President & CEO) has filed a Form 4 on Adicet Bio, Inc.
Txns:
| Granted 85,500 shares
@ $0 Granted 384,900 options to buy
@ $9.05, valued at
$3.5M
|
|
|
|
|